Login / Signup

The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration adverse event reporting system (FAERS).

Roger S McIntyreRodrigo B MansurJoshua D RosenblatAngela T H Kwan
Published in: Expert opinion on drug safety (2023)
Using the Bradford Hill criteria however and taking into consideration confounders, no causal link between GLP-1 RAs and suicidality exists.
Keyphrases
  • drug administration
  • adverse drug
  • wild type
  • electronic health record
  • human health
  • climate change
  • drug induced